Gut Bacteria Spread Between People Like Epidemics, Study Finds

If you've ever wondered whether the bacteria living in your gut are really "yours," a new genetic analysis suggests the picture is more contagious than that. Researchers who compared the genomes of tens of thousands of gut bacteria found that individual bacterial lineages can spread through the human population much like an epidemic, moving from person to person over decades until large numbers of unrelated people end up carrying nearly identical strains. Some of these spreading lineages line up statistically with colorectal cancer, inflammatory bowel disease and type 2 diabetes, raising the possibility that which specific version of a "normal" gut microbe you carry, not just whether you have it at all, matters for health.

Key takeaways:

• Scientists analyzed 16,864 gut bacteria genomes and 6,783 stool metagenomes and found that bacterial lineages regularly undergo "genome-wide selective sweeps," a process that lets one strain take over a niche and then spread between people in patterns that resemble slow epidemics.
• 178 of these bacterial lineages were statistically linked to colorectal cancer, Crohn's disease, ulcerative colitis, type 2 diabetes or age over 65, and 104 of those links held up across multiple independent populations.
• The study shows association, not proof of cause: it does not show that any single strain causes disease, and its estimates of how fast strains spread carry real uncertainty.

Genome-Wide Selective Sweeps Reshape Gut Bacteria Populations

A new study in Nature finds that gut bacteria populations are repeatedly reshaped by genome-wide selective sweeps (GWSS), a process in which one bacterial lineage picks up a genetic advantage, outcompetes its close relatives within its ecological niche, and then rediversifies into a tight cluster of nearly identical descendants. Led by researchers at the University of Vienna, the team analyzed genomes from 16,864 gut bacteria isolates and then cross-checked the pattern against 6,783 stool metagenomes (genetic material sequenced directly from stool samples, rather than from bacteria grown in a lab) to confirm it wasn't an artifact of which bacteria happen to be easy to culture. They found evidence of sweeps in at least 66 bacterial species spanning 25 bacterial families, for a total of 124 confirmed sweep clusters. On a family tree of related genomes, a sweep looks like a broom: a tight cluster of closely related descendants (the broom head) sitting at the end of an unusually long branch (the broom handle) that separates them from their nearest relatives.

Colorectal Cancer, IBD and Diabetes Patients Carry Distinct Strains

People living with colorectal cancer, Crohn's disease, ulcerative colitis or type 2 diabetes, along with adults over 65, a life stage already tied to distinctive shifts in gut microbiome composition, were statistically more likely to carry specific sweep-descended bacterial lineages than people without those conditions. Researchers tested for links between sweep clusters and five host conditions across their metagenome dataset and found 178 commensal (non-disease-causing, naturally resident) sweep clusters significantly associated with at least one of them; 104 of those associations held up across multiple independent datasets and geographic regions, meaning the pattern was not just a quirk of one country's diet or lab batch. Gut bacteria imbalances have already been linked to inflammatory bowel disease and colorectal cancer and to shared pathways between type 2 diabetes and colorectal cancer at the broader species level; this study adds a finer layer underneath that. One species, Bacteroides uniformis, a common gut commensal, illustrates why the distinction matters: when researchers split it into its four separate sweep clusters, each lineage showed a positive association with a different one of the five conditions studied, even though B. uniformis as a whole showed no association, or even a negative one, with those same conditions. Lumping bacteria together under one species name, in other words, can hide health-relevant genetic differences that only appear once the sweep-descended sublineages are separated out.

The 5x Rule Separated Real Sweeps From Random Drift

To avoid mistaking ordinary bacterial diversity for a genuine selective sweep, the researchers built a statistical test they call the "5x rule," which only counted a cluster of genomes as a sweep if its members were, on average, at least five times more genetically similar to each other than to their nearest relatives outside the cluster, a threshold chosen to keep the odds of a false call below 1%. Because bacteria routinely swap DNA segments with each other (a process called recombination) in ways that can mimic the signal of a sweep, the team first had to mathematically separate inherited mutations from recombined DNA in each genome before applying the test. They then validated their isolate-genome-based clusters against the independently collected metagenomes to rule out sampling bias. Part of the underlying dataset came from a cohort of 50 patients undergoing colorectal cancer screening colonoscopies at Vienna General Hospital, none of whom were found to have cancer, which contributed 186 newly sequenced bacterial genomes to the global collection.

What Sweep-Descended Strains Could Mean for Your Gut Health

For now, this discovery does not change anything a patient should do differently, because the study demonstrates a statistical association between certain bacterial lineages and disease, not proof that carrying one of these strains causes colorectal cancer, IBD or type 2 diabetes. There is no test currently available that tells an individual which sweep-descended lineage they carry, and no approved treatment or supplement targets these specific strains. What the finding does suggest is that future microbiome testing may eventually need finer resolution than species-level identification, since two people can carry "the same" bacterium by name while carrying genetically distinct lineages tied to different health outcomes. If you are already managing IBD, type 2 diabetes or colorectal cancer risk with a doctor, this research is a useful thing to be aware of as microbiome science develops, but it is not, on its own, a reason to request a specific test or change a treatment plan.

The Open Questions the Study Doesn't Yet Answer

The biggest caveat is that this is a correlational study, not a causal one: it cannot say whether a sweep-descended strain contributes to disease, is simply more successful in a gut environment that disease has already altered, or both. The authors also note that their sweep count is likely an undercount, since detecting a sweep depends on having enough closely related, previously sequenced isolate genomes to compare, meaning less-studied gut bacterial families almost certainly harbor undetected sweeps. The dating of these events carries real uncertainty too: age estimates rely on an assumed molecular clock of roughly 1 to 10 DNA changes per genome per year, and the researchers themselves describe the resulting ages, tens to thousands of years, as order-of-magnitude estimates rather than precise timelines. Finally, some individual disease-linked clusters were small; the four B. uniformis clusters averaged only about 5 samples each, so while the overall pattern held up across 104 clusters and multiple countries, any single lineage's disease link needs more data before it should be treated as settled.

Next Steps: Mapping Sweep Clusters as Disease Markers

The researchers say a next step is testing whether tracking genetically distinct sweep clusters, rather than bacterial species as a whole, could work as a more precise marker for conditions like colorectal cancer or inflammatory bowel disease. They also flagged a functional lead worth following: genes unique to individual sweep clusters were disproportionately involved in building capsular polysaccharides (sugar-coated molecules on the bacterial surface), which in other well-studied species such as Bacteroides fragilis and Bacteroides thetaiotaomicron are already known to help bacteria interact with, or evade, the immune system. That raises the possibility that immune interactions are part of what drives a winning lineage to take over its niche, though the paper frames this as a hypothesis for future work rather than a demonstrated mechanism. No clinical timeline was given, since the paper is a foundational evolutionary study, not a treatment trial.

Common Questions

What is a genome-wide selective sweep? It is when one bacterial lineage develops a genetic advantage, outcompetes its close relatives in its niche, and then diversifies again into a tight cluster of nearly identical descendants, which shows up on a genetic family tree as a cluster sitting at the end of an unusually long branch.

Does this mean gut bacteria are contagious like a cold? Not in that sense; the spread described in the study happens slowly, over years to centuries, likely through close contact, shared households and possibly food and water, with the researchers estimating some lineages take decades to spread across continents.

Should I get my microbiome tested because of this study? No specific test, treatment or supplement comes out of this research; it is a foundational finding about how gut bacteria evolve and spread, not a clinical recommendation.

Does carrying one of these strains mean I will develop IBD, cancer or diabetes? No. The associations described are statistical patterns seen across large populations, not predictions for any one person, and the study does not show that a strain causes these conditions.

References

1. Xiaoqian Annie Yu, Cameron R. Strachan, Craig W. Herbold, et al. (2026). Genome-wide sweeps create ecological units in the human gut microbiome. Nature. https://doi.org/10.1038/s41586-026-10476-w
2. Unique gut microbiome patterns linked to healthy aging, increased longevity. NIH. https://www.nia.nih.gov/news/unique-gut-microbiome-patterns-linked-healthy-aging-increased-longevity
3. Anpei Song (2025). Characteristics of Gut Microbiota in Inflammatory Bowel Disease and Colorectal Cancer. BIO Web of Conferences. https://doi.org/10.1051/bioconf/202517401004
4. Anns Mahboob, Chehbin Shin, Shahd Almughanni, Lubica Hornakova, Peter Kubatka, Dietrich Büsselberg (2025). The Gut Nexus: Unraveling Microbiota-Mediated Links Between Type 2 Diabetes and Colorectal Cancer. Nutrients. https://doi.org/10.3390/nu17233803